NASDAQ:AUTL | Free Cash Flow | Autolus Therapeutics plc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$65.32M$2.69M-$68.01M
2025-12-31-$67.32M-$885,000.00-$68.21M
2025-03-31-$75.57M$8.24M-$83.81M
2024-12-31-$37.93M$11.11M-$49.05M
2024-03-31-$40.51M$533,000.00-$41.05M
2023-12-31-$24.83M$1.48M-$26.31M
2023-03-31-$42.42M$3.62M-$46.04M
2022-12-31-$14.57M$633,000.00-$15.2M
2021-03-31-$37.34M$1.9M-$39.24M
2020-12-31-$27.73M$5.47M-$33.2M
2020-03-31-$24.03M$2.64M-$26.67M
2019-12-31-$33.27M$1.59M-$34.85M
2019-03-31-$26.52M$7.33M-$33.85M
2018-12-31-$19.79M$4.42M-$24.21M
2017-12-31-$8.8M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$283.57M$19.04M-$302.61M
2024-12-31-$206.27M$22.08M-$228.35M
2023-12-31-$145.59M$10.99M-$156.57M
2022-12-31-$112.31M$10.84M-$123.15M
2021-12-31-$117.86M$8.86M-$126.72M
2020-12-31-$117.76M$14.68M-$132.44M
2019-12-31-$101.48M$18.34M-$119.83M
2018-09-30-$31.54M$9.12M-$40.66M
2017-09-30-$16.36M$2.88M-$19.24M
2016-09-30-$9.85M$1.86M-$11.7M